SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending following a Supreme Court ruling that struck down tariffs, challenging a core element of former President Trump's past economic policy and executive power. The community is widely debating the financial implications for consumers and businesses, including the prospect of significant tariff refunds, and the broader political repercussions.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

The Supreme Court's ruling against Trump-era tariffs is driving conversation and a rally in SPY, as many perceive it as disinflationary and supportive of potential rate cuts, though bears remain skeptical, citing other concerning economic data and anticipating a market pullback.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is seeing active discussion following reports regarding a partner's challenges in securing financing for a data center, a narrative largely countered by denials from the involved companies and speculation among traders about pre-earnings market manipulation.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is actively trending amid discussions of its strategic investments in AI-enabled defense systems and new product unveilings, with the community highly anticipating a potential short squeeze driven by significant call options activity and broader sector momentum in drone dominance programs.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike (NKE) is trending as the community expresses confusion over its recent sell-off, with many attributing the decline to market manipulation or a "sell the news" event, despite discussions around potential tariff relief and the company's restructuring efforts including layoffs. Investors are actively debating if NKE is a value trap or a prime opportunity for a long-term turnaround, especially given broader sector comparisons and concerns over its recent performance in key markets.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is a focus of debate after its recent earnings showed massive ARR growth and its first positive adjusted EBITDA, yet some investors link its volatility to broader AI infrastructure funding challenges. Despite this, significant institutional accumulation and bullish analyst upgrades are driving a strong community conviction in its undervalued growth trajectory as a leading AI hyperscaler.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is experiencing significant volatility following the Supreme Court's decision to strike down President Trump's emergency tariffs, prompting a divided community discussion between bullish sentiment for potential lower inflation and rate cuts, and concerns over Trump's promised "backup plan" for tariffs and broader market uncertainty.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending following a dual financing announcement, including a $100 million public stock offering priced at $5.45 per share and a $100 million royalty funding deal with RTW Investments. While some in the community express concern over significant dilution, others view this as a strategic move that secures crucial runway for commercialization and validates the company's lead asset, CAN-2409, ahead of its BLA submission and ongoing trials.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Berkeley Heights, NJ.

Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals is trending due to the early commercial success of its newly launched fibromyalgia drug, Tonmya, which is reportedly exceeding initial sales expectations and gaining broader insurance coverage. Despite persistent community frustration over historical share dilution and price performance, institutional investors are significantly increasing their positions, signaling confidence in the company's transition to a revenue-generating biotech with a promising non-opioid pain pipeline.

GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.

GRAIL Inc.

GRAIL is trending due to a substantial stock decline following mixed results from its NHS-Galleri trial, which missed its primary endpoint for reducing late-stage cancers but showed promising data in early detection, leading to sharp debate between those who see an overreaction and others predicting further declines.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Northwest Biotherapeutics, Inc. is a biotechnology company, which engages in the development of personalized immune therapies for cancer. It offers DCVax technology platform, which uses activated dendritic cells to mobilize a patient’s own immune system to attack their cancer. The company was founded by Alton L. Boynton on March 18, 1996 and is headquartered in Bethesda, MD.

Current Price	$0.2415
Prev Close	$0.2449
Open	$0.25
Dividend Yield	0.00%
50-Day Moving Average	$0.2623
Beta	0.00
Avg. Volume	3.9M
PE Ratio	-3.72

52-Week High	$0.4788
52-Week Low	$0.1684
Market Capitalization	$377.31M
EPS (Annual)	-$0.0686
Price to Book	-3.42
Revenue Per Employee	$55,280.00

NWBO
Northwest Biotherapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest NWBO News

NWBONorthwest Biotherapeutics Inc